
Mercy Infusion supports patients with complex immune, neurologic, hematologic, and specialty conditions that may require physician-directed infusion therapy.
Our team works closely with prescribing providers, patients, caregivers, and health plans to help coordinate care, reduce delays, and support treatment access.
CIDP Treatment
Chronic Inflammatory Demyelinating Polyneuropathy, or CIDP, is a neurologic condition that may be treated with IVIG therapy to help manage symptoms and support long-term function.
Myasthenia Gravis (MG) Treatment
Myasthenia gravis is an autoimmune neuromuscular condition that may require infusion therapy, including IVIG, depending on the patient’s symptoms and provider’s treatment plan.
[Myasthenia Gravis (MG) Treatment]
Guillain-Barré Syndrome (GBS) Treatment
Guillain-Barré syndrome is a rare neurologic condition that can develop quickly and may require timely IVIG therapy and coordinated care.
[Guillain-Barré Syndrome (GBS) Treatment]
Primary Immunodeficiency (PI/CVID) Treatment
Primary immunodeficiency, including CVID, affects the body’s ability to fight infections. IVIG or SCIG therapy may help support immune function and reduce infections.
[Primary Immunodeficiency (PI/CVID) Treatment]
Treatment Coordination and Support
For many patients, starting therapy is not just about the medication. It also involves insurance review, prior authorization, scheduling, and ongoing communication.
Mercy Infusion helps patients and providers by:
Start Care With Mercy Infusion
If you or a loved one has been prescribed infusion therapy for one of these conditions, Mercy Infusion can help coordinate the next steps.